Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?

被引：4

作者：

Kucharz, Eugeniusz Jozef ^{[1
]}

Kotulska-Kucharz, Anna ^{[1
]}

机构：

[1] Med Univ Silesia, Dept Internal Med Rheumatol & Clin Immunol, 45-47 Ziolowa St, PL-40635 Katowice, Poland

来源：

REUMATOLOGIA | 2021年 / 59卷 / 02期

关键词：

D O I：

10.5114/reum.2021.105438

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：65 / 67

页数：3

共 10 条

[1] Demyelinating events in rheumatoid arthritis after drug exposures [J].

Bernatsky, Sasha ;

Renoux, Christel ;

Suissa, Samy .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (09) :1691-1693

[2] Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications [J].

Bitoun, Samuel ;

Miceli-Richard, Corinne ;

Verstuyft, Celine ;

Juge, Pierre Antoine ;

Dieude, Philippe ;

Berthelot, Jean-Marie ;

Richez, Christophe ;

Cauquil, Cecile ;

Sordet, Christelle ;

Melac-Ducamp, Sylvie ;

Gossec, Laure ;

Bouvard, Beatrice ;

Dernis, Emmanuelle ;

Houvenagel, Eric ;

Boutry-Bacle, Marie-Astrid ;

Mariette, Xavier ;

Seror, Raphaele .

ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (12) :1835-+

[3] Monoclonal antibody therapy-associated neurological disorders [J].

Bosch, Xavier ;

Saiz, Albert ;

Ramos-Casals, Manuel .

NATURE REVIEWS NEUROLOGY, 2011, 7 (03) :165-172

[4] Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy [J].

Cortese, Rosa ;

Prosperini, Luca ;

Stasolla, Alessandro ;

Haggiag, Shalom ;

Villani, Veronica ;

Simone, Isabella Laura ;

Gasperini, Claudio ;

Tortorella, Carla .

JOURNAL OF NEUROLOGY, 2021, 268 (08) :2895-2899

[5] Tumor necrosis factor inhibitors and risk of peripheral neuropathy in patients with rheumatic diseases [J].

Etminan, Mahyar ;

Sodhi, Mohit ;

Samii, Ali ;

Carleton, Bruce C. ;

Kezouh, Abbas ;

Avina-Zubieta, J. Antonio .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) :1083-1086

[6] Demyelination and other neurological adverse events after anti-TNF therapy [J].

Kaltsonoudis, Evripidis ;

Voulgari, Paraskevi V. ;

Konitsiotis, Spyridon ;

Drosos, Alexandros A. .

AUTOIMMUNITY REVIEWS, 2014, 13 (01) :54-58

[7] Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden [J].

Kopp, Tine Iskov ;

Delcoigne, Benedicte ;

Arkema, Elizabeth V. ;

Jacobsen, Rikke Kart ;

Magyari, Melinda ;

Ibfelt, Else Helene ;

Locht, Henning ;

Sellebjerg, Finn ;

Cordtz, Rene Lindholm ;

Jensen, Dorte V. ;

Askling, Johan ;

Dreyer, Lene .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (05) :566-572

[8] Treatment with infliximab may contribute to the development of peripheral neuropathy among the patients with rheumatoid arthritis [J].

Kotyla, Przemyslaw J. ;

Sliwinska-Kotyla, Bogna ;

Kucharz, Eugene J. .

CLINICAL RHEUMATOLOGY, 2007, 26 (09) :1595-1596

[9] Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey [J].

Seror, Raphaele ;

Richez, Christophe ;

Sordet, Christelle ;

Rist, Stephanie ;

Gossec, Laure ;

Direz, Guillaume ;

Houvenagel, Eric ;

Berthelot, Jean-Marie ;

Pagnoux, Christian ;

Dernis, Emmanuelle ;

Melac-Ducamp, Sylvie ;

Bouvard, Beatrice ;

Asquier, Caroline ;

Martin, Antoine ;

Puechal, Xavier ;

Mariette, Xavier .

RHEUMATOLOGY, 2013, 52 (05) :868-874

[10] Demyelinating disorders secondary to TNF-inhibitor therapy for the treatment of psoriasis: A review [J].

Zhu, Tian Hao ;

Nakamura, Mio ;

Abrouk, Michael ;

Farahnik, Benjamin ;

Koo, John ;

Bhutani, Tina .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2016, 27 (05) :406-413

← 1 →